Joel P. Berger

Statistics

Publications

Citations

11.1K

H-Index

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Université Laval

Albert Einstein College of Medicine

Joel P. Berger is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, life sciences, and peroxisome proliferator-activated receptors.

Publications per year

1989–2023

Publications

Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity

Utpal B. Pajvani, Meredith Hawkins, Terry P. Combs et al. · Journal of Biological Chemistry · 2004 · 1.2K citations · Full text

Medicine, Biochemistry, Endocrinology +15

Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells

Qiang Tian, Serguei Stepaniants, Mao Mao et al. · Molecular & Cellular Proteomics · 2004 · 783 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

E. Robert McDonald, Antoine de Weck, Michael R. Schlabach et al. · Cell · 2017 · 701 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization

Terry P. Combs, John A. Wagner, Joel P. Berger et al. · Endocrinology · 2002 · 568 citations

Medicine, Endocrinology, Pharmacology +17

Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects

Joel P. Berger, Mark D. Leibowitz, Thomas W. Doebber et al. · Journal of Biological Chemistry · 1999 · 412 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–5 of 93